أجريت هذه الدراسة لإثبات دور الهبسيدين في تقدير حالة الحديد لدى مرضى التحال الدموي . تناولت الدراسة 88 مريضاً لديهم داء كلوي بمراحله النهائية ESRD)End Stage Renal Disease) و معالجين بالتحال الدموي في قسم الكلية الصناعية في مشفى الأسد الجامعي في اللاذقية.
تم قياس تركيز الهبسيدين و تركيز الفريتين, و حساب نسبة إشباع الترانسفرين (TSAT) بعد قياس السعة الكلية الرابطة للحديد (TIBC)، و من ثم تم ربط هذه الواسمات مع الحديد و قورنت من حيث الارتباط الأقوى.
تبين من خلال هذه الدراسة أن تركيز الهبسيدين مرتفع لدى جميع مرضى الدراسة، بالإضافة لوجود علاقة ذات دلالة هامة إحصائياً بين الحديد و الهبسيدين، حيث إن قيمة P-VALUE أصغر من 0.05, و هذه العلاقة علاقة عكسية, و قوة الارتباط في هذه العلاقة 40%، و عند المقارنة مع قوة ارتباط الواسمات الأخرى مع الحديد كان للهبسيدين الإرتباط الأقوى .
الخلاصة :
يمكن أن يشارك ارتفاع مستوى الهبسيدين لدى مرضى التحال الدموي في التنظيم غير الطبيعي للحديد و في مقاومة تكون الكريات الحمر، كما يمكن أن يكون الهبسيدين واسماً جديداً للحديد لدى هؤلاء المرضى.
This study is conducted to assess the role of hepcidin as a biomarker of iron status in haemodialysis patients. The study included88 patients who had end-stage renal disease ( ESRD), and were treated with haemodialysis in the Department of Renal Medicine in Al-Assad University Hospital in Lattakia.
Serum hepcidin and ferritinlevelswere measured, and transferrin saturation (TSAT) was calculated after measuringthe total iron binding capacity (TIBC), these markers were then attached with iron and compared to know the hardest correlation.
Results show that all the patients had high serum hepcidin levels,there was a statistically significant relation between iron and hepcidin, where P-VALUE smaller than 0.05, this relationship was inversal, hardly 40% the stongest correlation.
Conclusion:
These findings suggest that the increased hepcidinin haemodialysis patients may contribute to abnormal ironregulation and erythropoiesis, and may be a novel biomarker of iron status and erythropoietin resistance.
References used
Andrews NC .Disorders of iron metabolism.-`N Engl J Med. 341: 1986-1995, 1999
Finch C .Regulators of iron balance in humans .Blood. 84: 1697-1702, 1994
Ganz T .Hepcidin, a key regulator of iron metabolism and mediator of anemia ofinflammation .Blood. 102 (3): 783-788, 2003
Roetto A; Papanikolaou G; Politou M. et al .Mutant antimicrobial peptide hepcidin is associated with severe juvenilehemochromatosis .Nat Genet. 33: 21-22, 2003
Fleming RE .Advances in understanding themolecular basis for the regulation of dietary iron absorption .Curr Opin Gastroenterol. 21: 201-206, 2005
Worldwide, iron deficiency anemia (IDA) is the most common nutritional deficiency,
and its management remains a challenge in many cases.(OIT)Oral iron therapy, in appropriate
doses and for a sufficient duration, is an effective first-line strategy
Bladder cancer is the most common malignancy of the urinary
tract, and has the fastest rate of recurrence which gives it high
prevalence of tumors all over the world. Early diagnosis is very
important for treatment efficacy, prevent tumor progress
Hepcidin-25 is a peptide hormone plays an important role in
regulating the systematic iron homeostasis. This paper was
conducted to study the correlations of Hepcidin with some iron
status markers and red cell indices among patients with iron
def
Mitochondria are the major organelles in eukaryotic cells primarily responsible for many cellular functions. Recently, a decrease or increase in mtDNA copy number has been increasingly recognized in human cancers.
The aim of this study was to estimate the total amount of phenolic compounds of olive
trees leaves (Olea europaea L.) as Biomarker for the assessment of lead air pollution at
Banias area. Olive trees were selected as the predominant species in the